Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
FDA records second original approval for Amgen's PavbluOct 22Regulatory decisionaflibercept-ayyhAmgen
Sign inSign in